Home

Effectiveness Trial Of Attention Shaping For Schizophrenia

Steven M Silverstein, Associate Professor
Psychiatryuniv Of Med/dent Nj-r W Johnson Med Sch

Grant 5R01MH074650-03 from National Institute Of Mental Health, IRG: APDA

Abstract: Among people with schizophrenia, attentional impairment is a major barrier to being able to engage in, and learn new skills in, psychosocial skills training interventions. Therefore, developing methods to promote attentiveness and learning during skills training is an important step in improving treatment outcomes. Prior case reports, one controlled study, and data from an ongoing R21 application indicate that attention shaping procedures (ASP) are highly effective methods to achieve these goals. ASP is a manualized, behavioral intervention that involves individualized goal-setting, and standardized observational rating, prompting, and reinforcement procedures to assist patients in increasing the duration and quality of their attentiveness in psychosocial interventions. To date, studies of ASP have been limited in their outcome evaluations to in- group attentiveness and learning of group material. Other cognitive outcomes, generalizability, functional outcomes and durability of gains have not been studied. This proposal, therefore, describes a controlled effectiveness study of ASP that would comprehensively assess relevant outcomes, generalizability, functional skills related to those taught in the intervention and maintenance of the gains over six months. ASP will be integrated within a standard form of social skills training [UCLA Basic Conversation Skills Module (BCS)], and compared to a BCS-alone condition. Specific aims of the study involve examinations of 1) the generalizability of ASP´s effects to relevant domains of non-study-group attentiveness, and standardized measures of neurocognition; 2) functional outcomes involving social skills, as assessed through self-report, other-report, interview, and role-play based measures; and 3) the durability of ASP-associated gains, by conducting a 6-month follow-up assessment on all subjects. Statistical analyses will involve time-series and growth curve models that make use of daily in-group performance data to model treatment response. These data, plus more traditional analyses will determine whether, and to what extent, ASP confers advantages in attention, and learning and/or performance of behavioral skills to patients who receive it. The long-term objective of this project is to demonstrate that ASP can narrow the gap between the existence of potentially effective psychosocial interventions (such as skills training) and patients who, at present, cannot benefit from them due to attentional difficulties

Keywords: attention, behavior modification, behavior therapy, human therapy evaluation, psychosocial rehabilitation, schizophrenia clinical trial, outcomes research, reinforcer behavioral /social science research tag, clinical research, human subject, medical rehabilitation related tag, neuropsychological test, patient oriented research

Project start date: 2006-09-14

Project end date: 2011-07-31


Sponsored Links Lab Supply Mall http://www.labsupplymall.com

New Invitrogen UltraPure Agarose 500g
UltraPure Agarose resolves DNA and RNA fragments from 100 bp to >30 kb. $432, $350
GenJetTM In Vitro DNA Transfection Reagent
A more affordable alternative to Invitrogen's lipofetacmine 2000. $178, $139
Qiagen QIAEX II Gel Extraction Kit (150), Cat # 20021
For batch purification of DNA fragments (40 bp to 50 kb) from agarose gels and from solutions. $137, $105
Qiagen EndoFree Plasmid Maxi Kit (10), Cat # 12362
For purification of up to 500 ug advanced transfection grade plasmid or cosmid DNA. $266, $210
Qiagen RNeasy Mini Kit (50), Cat # 74104
For purification of up to 100 ug total RNA from animal cells or tissues, yeast, or bacteria. $219, $170
Qiagen Plasmid Maxi Kit (25), Cat # 12163
For purification of up to 500 ug transfection grade plasmid or cosmid DNA. $454, $395
QIAGEN Plasmid Maxi Kit (10), Cat # 12162
For purification of up to 500 ug transfection grade plasmid or cosmid DNA. $192, $150
Invitrogen Life Technology Gibo Lipofectamine 2000, 1.5 ml, Cat 11668-019
Unsurpassed Results for DNA and siRNA Transfections. $399, $350
Amersham ECL Plus Western Blotting Detection Reagents, Cat # RPN2132
Superior sensitivity.. $230, $55
Invitrogen NuPAGE Novex 4-12% Bis-Tris Gels
Best resolution and most consistent results,long shelf-life - at least 8 months! . $117.5, $95

Effectiveness Trial Of Attention Shaping For Schizophrenia

Steven M Silverstein, Associate Professor
Univ Of Med/dent Nj-r W Johnson Med Sch Robert Wood Johnson Medical Sch Piscataway, Nj 088548021

Grant 5R01MH074650-02 from National Institute Of Mental Health, IRG: APDA

Abstract: Among people with schizophrenia, attentional impairment is a major barrier to being able to engage in, and learn new skills in, psychosocial skills training interventions. Therefore, developing methods to promote attentiveness and learning during skills training is an important step in improving treatment outcomes. Prior case reports, one controlled study, and data from an ongoing R21 application indicate that attention shaping procedures (ASP) are highly effective methods to achieve these goals. ASP is a manualized, behavioral intervention that involves individualized goal-setting, and standardized observational rating, prompting, and reinforcement procedures to assist patients in increasing the duration and quality of their attentiveness in psychosocial interventions. To date, studies of ASP have been limited in their outcome evaluations to in- group attentiveness and learning of group material. Other cognitive outcomes, generalizability, functional outcomes and durability of gains have not been studied. This proposal, therefore, describes a controlled effectiveness study of ASP that would comprehensively assess relevant outcomes, generalizability, functional skills related to those taught in the intervention and maintenance of the gains over six months. ASP will be integrated within a standard form of social skills training [UCLA Basic Conversation Skills Module (BCS)], and compared to a BCS-alone condition. Specific aims of the study involve examinations of 1) the generalizability of ASP s effects to relevant domains of non-study-group attentiveness, and standardized measures of neurocognition; 2) functional outcomes involving social skills, as assessed through self-report, other-report, interview, and role-play based measures; and 3) the durability of ASP-associated gains, by conducting a 6-month follow-up assessment on all subjects. Statistical analyses will involve time-series and growth curve models that make use of daily in-group performance data to model treatment response. These data, plus more traditional analyses will determine whether, and to what extent, ASP confers advantages in attention, and learning and/or performance of behavioral skills to patients who receive it. The long-term objective of this project is to demonstrate that ASP can narrow the gap between the existence of potentially effective psychosocial interventions (such as skills training) and patients who, at present, cannot benefit from them due to attentional difficulties.

Keywords: attention, behavior modification, behavior therapy, human therapy evaluation, psychosocial rehabilitation, schizophrenia, clinical trial, outcomes research, reinforcer, behavioral /social science research tag, clinical research, human subject, medical rehabilitation related tag, neuropsychological test, patient oriented research

Project start date: 2006-09-14

Project end date: 2011-07-31

5R01MH074650-02 (2007): $455946



Grants awarded to Steven M Silverstein

Shaping Attention In Treatment-Refractory Schizophrenia

Steven M Silverstein, Associate Professor
University Of Illinois At Chicago 310 Aob, M/c 672 Chicago, Il 60612

Grant 5R21MH063967-04 from National Institute Of Mental Health, IRG: ZRG1

Abstract: Despite pharmacologic treatment advances, there are many treatment-refractory schizophrenia patients remaining in state hospitals. Many of these patients are sufficiently cognitively impaired that they benefit little from psychosocial interventions and have little chance of returning to the community without the introduction of novel cognition-enhancing interventions. Moreover, many patients who have been discharged from state hospitals in the wake of recent census reductions also have attentional problems that preclude their ability to fully engage in, and benefit from, psychosocial interventions. Such patients can be considered at heightened risk for relapse and rehospitalization as long as their limited ability to benefit from treatment remains undressed. Compounding this problem is the inability of current cognitive rehabilitation interventions to improve attentional functioning in schizophrenia patients with the most severe attentional problems. For such patients, behaviorally oriented attention shaping procedures have demonstrated effectiveness in several small-scale studies. However, the lack of a user-friendly, standardized format for the delivery of this intervention has led to its almost complete nonuse outside of academic research centers. Therefore, the proposed study seeks to draw on the expertise of those investigators who have pioneered the use of shaping techniques to improve attention in treatment-refractory schizophrenia patients, in order to integrate these techniques into a standardized, manualized treatment intervention, along with an accompanying training videotape and therapist fidelity evaluation measure. The proposed project would develop this standardized treatment delivery format, and then refine it through a series of pilot treatment groups at three sites Weill Medical College of Cornell University, Lincoln Regional Center, and Hawaii State Hospital. In addition, data would be collected and pooled regarding treatment-related changes in attentional functioning, skill acquisition in groups, and symptomatology. The expected results of this project include 1) the development of a user-friendly set of materials to facilitate dissemination of the attention shaping intervention to real-world settings; 2) the collection of preliminary data on its effectiveness; and 3) the generation of estimates of power and subject variability which can serve as the foundation from which to design a large-scale controlled treatment study.

Keywords: attention, computer assisted patient care, computer program /software, human therapy evaluation, method development, neuropsychology, psychotherapy, schizophrenia, computer human interaction, handbook, information dissemination, learning, outcomes research, reinforcer, videotape /videodisc, behavioral /social science research tag, clinical research, data collection methodology /evaluation, human subject, interview, mental disorder diagnosis, patient oriented research, psychological test

Project start date: 2003-02-14

Project end date: 2007-01-31

5R21MH063967-04 (2005): $211187


5R21MH063967-03 (2004): $172878

Shaping Attention In Treatment--Refractory Schizophrenia

Steven M Silverstein, Associate Professor
Weill Medical College Of Cornell Univ 1300 York Avenue New York, Ny 10021

Grant 1R21MH063967-01A2 from National Institute Of Mental Health, IRG: ZRG1

Abstract: Despite pharmacologic treatment advances, there are many treatment-refractory schizophrenia patients remaining in state hospitals. Many of these patients are sufficiently cognitively impaired that they benefit little from psychosocial interventions and have little chance of returning to the community without the introduction of novel cognition-enhancing interventions. Moreover, many patients who have been discharged from state hospitals in the wake of recent census reductions also have attentional problems that preclude their ability to fully engage in, and benefit from, psychosocial interventions. Such patients can be considered at heightened risk for relapse and rehospitalization as long as their limited ability to benefit from treatment remains undressed. Compounding this problem is the inability of current cognitive rehabilitation interventions to improve attentional functioning in schizophrenia patients with the most severe attentional problems. For such patients, behaviorally oriented attention shaping procedures have demonstrated effectiveness in several small-scale studies. However, the lack of a user-friendly, standardized format for the delivery of this intervention has led to its almost complete nonuse outside of academic research centers. Therefore, the proposed study seeks to draw on the expertise of those investigators who have pioneered the use of shaping techniques to improve attention in treatment-refractory schizophrenia patients, in order to integrate these techniques into a standardized, manualized treatment intervention, along with an accompanying training videotape and therapist fidelity evaluation measure. The proposed project would develop this standardized treatment delivery format, and then refine it through a series of pilot treatment groups at three sites Weill Medical College of Cornell University, Lincoln Regional Center, and Hawaii State Hospital. In addition, data would be collected and pooled regarding treatment-related changes in attentional functioning, skill acquisition in groups, and symptomatology. The expected results of this project include 1) the development of a user-friendly set of materials to facilitate dissemination of the attention shaping intervention to real-world settings; 2) the collection of preliminary data on its effectiveness; and 3) the generation of estimates of power and subject variability which can serve as the foundation from which to design a large-scale controlled treatment study.

Keywords: attention, computer assisted patient care, computer program /software, human therapy evaluation, method development, neuropsychology, psychotherapy, schizophrenia, computer human interaction, handbook, information dissemination, learning, outcomes research, reinforcer, videotape /videodisc, behavioral /social science research tag, clinical research, data collection methodology /evaluation, human subject, interview, mental disorder diagnosis, patient oriented research, psychological test

Project start date: 2003-02-14

Project end date: 2003-09-26

1R21MH063967-01A2 (2003): $141280


Effectiveness Trial Of Attention Shaping For Schizophrenia

Steven M Silverstein, Associate Professor
Psychiatryuniv Of Med/dent Nj-r W Johnson Med Sch

Grant 5R01MH074650-03 from National Institute Of Mental Health, IRG: APDA

Abstract: Among people with schizophrenia, attentional impairment is a major barrier to being able to engage in, and learn new skills in, psychosocial skills training interventions. Therefore, developing methods to promote attentiveness and learning during skills training is an important step in improving treatment outcomes. Prior case reports, one controlled study, and data from an ongoing R21 application indicate that attention shaping procedures (ASP) are highly effective methods to achieve these goals. ASP is a manualized, behavioral intervention that involves individualized goal-setting, and standardized observational rating, prompting, and reinforcement procedures to assist patients in increasing the duration and quality of their attentiveness in psychosocial interventions. To date, studies of ASP have been limited in their outcome evaluations to in- group attentiveness and learning of group material. Other cognitive outcomes, generalizability, functional outcomes and durability of gains have not been studied. This proposal, therefore, describes a controlled effectiveness study of ASP that would comprehensively assess relevant outcomes, generalizability, functional skills related to those taught in the intervention and maintenance of the gains over six months. ASP will be integrated within a standard form of social skills training [UCLA Basic Conversation Skills Module (BCS)], and compared to a BCS-alone condition. Specific aims of the study involve examinations of 1) the generalizability of ASP´s effects to relevant domains of non-study-group attentiveness, and standardized measures of neurocognition; 2) functional outcomes involving social skills, as assessed through self-report, other-report, interview, and role-play based measures; and 3) the durability of ASP-associated gains, by conducting a 6-month follow-up assessment on all subjects. Statistical analyses will involve time-series and growth curve models that make use of daily in-group performance data to model treatment response. These data, plus more traditional analyses will determine whether, and to what extent, ASP confers advantages in attention, and learning and/or performance of behavioral skills to patients who receive it. The long-term objective of this project is to demonstrate that ASP can narrow the gap between the existence of potentially effective psychosocial interventions (such as skills training) and patients who, at present, cannot benefit from them due to attentional difficulties

Keywords: attention, behavior modification, behavior therapy, human therapy evaluation, psychosocial rehabilitation, schizophrenia clinical trial, outcomes research, reinforcer behavioral /social science research tag, clinical research, human subject, medical rehabilitation related tag, neuropsychological test, patient oriented research

Project start date: 2006-09-14

Project end date: 2011-07-31


1R01MH074650-01A1 (2006): $446350


Related Publications

Horton HK, Silverstein SM.
Abstract Social cognition as a mediator of cognition and outcome among deaf and hearing people with schizophrenia. Schizophr Res. 2008 Oct; 105( 1-3): 125-37. Epub 2008 Aug 22. PMID: 18722092

Butler PD, Silverstein SM, Dakin SC.
Free in PMC Visual perception and its impairment in schizophrenia. Biol Psychiatry. 2008 Jul 1; 64( 1): 40-7. PMID: 18549875

Silverstein SM.
Abstract Measuring specific, rather than generalized, cognitive deficits and maximizing between-group effect size in studies of cognition and cognitive change. Schizophr Bull. 2008 Jul; 34( 4): 645-55. Epub 2008 May 8. Review. PMID: 18468987

Silverstein SM, Bellack AS.
Abstract A scientific agenda for the concept of recovery as it applies to schizophrenia. Clin Psychol Rev. 2008 Oct; 28( 7): 1108-24. Epub 2008 Mar 18. PMID: 18420322

Shankman SA, Silverstein SM, Williams LM, Hopkinson PJ, Kemp AH, Felmingham KL, Bryant RA, McFarlane A, Clark CR.
Abstract Resting electroencephalogram asymmetry and posttraumatic stress disorder. J Trauma Stress. 2008 Apr; 21( 2): 190-8. PMID: 18404640

Silverstein SM, Spaulding WD, Menditto AA, Savitz A, Liberman RP, Berten S, Starobin H.
Abstract Attention Shaping: a Reward-Based Learning Method to Enhance Skills Training Outcomes in Schizophrenia. Schizophr Bull. 2008 Jan 22. [Epub ahead of print] PMID: 18212327

Green MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R.
Abstract Social Cognition in Schizophrenia: An NIMH Workshop on Definitions, Assessment, and Research Opportunities. Schizophr Bull. 2008 Nov; 34( 6): 1211-20. Epub 2008 Jan 8. PMID: 18184635

Silverstein SM, Berten S, Olson P, Paul R, Willams LM, Cooper N, Gordon E.
Abstract Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro. Behav Res Methods. 2007 Nov; 39( 4): 940-9. PMID: 18183911

Horton HK, Silverstein SM.
Abstract Cognition and functional outcome among deaf and hearing people with schizophrenia. Schizophr Res. 2007 Aug; 94( 1-3): 187-96. Epub 2007 Jun 7. PMID: 17560083

Uhlhaas PJ, Phillips WA, Schenkel LS, Silverstein SM.
Abstract Theory of mind and perceptual context-processing in schizophrenia. Cognit Neuropsychiatry. 2006 Jul; 11( 4): 416-36. PMID: 17354079

Uhlhaas PJ, Phillips WA, Mitchell G, Silverstein SM.
Abstract Perceptual grouping in disorganized schizophrenia. Psychiatry Res. 2006 Dec 7; 145( 2-3): 105-17. Epub 2006 Nov 1. PMID: 17081620

Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.
Abstract Comparing bimatoprost and travoprost in black Americans. Curr Med Res Opin. 2006 Nov; 22( 11): 2175-80. PMID: 17076978

Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.
Abstract A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther. 2006 May-Jun; 23( 3): 385-94. PMID: 16912020

Fiszdon JM, McClough JF, Silverstein SM, Bell MD, Jaramillo JR, Smith TE.
Abstract Learning potential as a predictor of readiness for psychosocial rehabilitation in schizophrenia. Psychiatry Res. 2006 Aug 30; 143( 2-3): 159-66. Epub 2006 Jul 24. PMID: 16860881

Hatashita-Wong M, Smith TE, Silverstein SM, Hull JW, Willson DF.
Abstract Cognitive functioning and social problem-solving skills in schizophrenia. Cognit Neuropsychiatry. 2002 May; 7( 2): 81-95. PMID: 16571529 [PubMed]
Silverstein SM, Bakshi S, Nuernberger S, Carpinello K, Wilkniss S.
Abstract Effects of stimulus structure and target-distracter similarity on the development of visual memory representations in schizophrenia. Cognit Neuropsychiatry. 2005 Jun; 10( 3): 215-29. PMID: 16571460 [PubMed]
Silverstein SM, Hatashita-Wong M, Schenkel LS, Wilkniss S, Kovács I, Fehér A, Smith T, Goicochea C, Uhlhaas P, Carpiniello K, Savitz A.
Abstract Reduced top-down influences in contour detection in schizophrenia. Cognit Neuropsychiatry. 2006 Mar; 11( 2): 112-32. PMID: 16537237

Uhlhaas PJ, Silverstein SM.
Abstract Perceptual organization in schizophrenia spectrum disorders: empirical research and theoretical implications. Psychol Bull. 2005 Jul; 131( 4): 618-32. Review. PMID: 16060805

Silverstein SM, Hatashita-Wong M, Solak BA, Uhlhaas P, Landa Y, Wilkniss SM, Goicochea C, Carpiniello K, Schenkel LS, Savitz A, Smith TE.
Abstract Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients. Psychol Med. 2005 Jun; 35( 6): 829-37. PMID: 15997603

Schenkel LS, Spaulding WD, Silverstein SM.
Abstract Poor premorbid social functioning and theory of mind deficit in schizophrenia: evidence of reduced context processing? J Psychiatr Res. 2005 Sep; 39( 5): 499-508. Epub 2005 Mar 4. PMID: 15992559